FDA Approved: MIFEPRISTONE — Supplemental Application (Corcept Therapeutics Incorporated)

View source ↗

Summary

FDA is reviewing a supplemental application for Mifepristone by Corcept Therapeutics. This action typically accompanies changes to labeling or approved indicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• Korlym (mifepristone)

Snippet

SUPPL AP for MIFEPRISTONE (MIFEPRISTONE)